Tech Company Financing Transactions
PreludeDx Funding Round
PreludeDx closed a $20 million investment round on 3/22/2022. Backers included Evidity Health Capital.
Transaction Overview
Company Name
Announced On
3/22/2022
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
Evidity Health Capital (Lead Investor) (Alejandro Sanchez)
Proceeds Purpose
Advance Growth Initiatives and Development of Its Precision Medicine Portfolio
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
26051 Merit Cir #103
Laguna Hills, CA 92653
United States
Laguna Hills, CA 92653
United States
Phone
Website
Email Address
Not Recorded
Overview
PreludeDx has focused on developing breast cancer tools that will impact a patient's treatment decision.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Andrew Wade
Chief Scientific Officer
Troy Bremer
President
Daniel Forche
Vice President
Cory Dunn
Vice President
Andrew Sundberg
Vice President
Matthew Tate
Browse more venture capital transactions:
Prev: 3/22/2022: WedgeHR venture capital transaction
Next: 3/22/2022: Better & Better venture capital transaction
Share this article
About Database of VC Transactions
We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs